Skip to main content
LUMIBIRD logo

LUMIBIRD — Investor Relations & Filings

Ticker · LBIRD ISIN · FR0000038242 LEI · 969500MLJC3ZSZP4L019 PA Manufacturing
Open in API
Filings indexed 560 across all filing types
Latest filing 2022-06-07 Share Issue/Capital Cha…
Country FR France
Listing PA LBIRD

About LUMIBIRD

https://www.lumibird.com/en/

LUMIBIRD is a leading specialist in laser technologies with over 50 years of experience. The company designs and manufactures high-performance lasers based on its expertise in three key technologies: solid-state lasers, fiber lasers, and laser diodes. It operates through two primary divisions. The Photonics division provides advanced laser solutions for applications in defense, space, environmental monitoring (including Lidar sensors), industrial manufacturing, and scientific research. The Medical division offers innovative ophthalmological and medical solutions, ranging from diagnostic equipment to laser treatment systems, through brands such as Quantel Medical and Ellex.

Recent filings

Filing Released Lang Actions
LUMIBIRD SELECTED AMONG EURONEXT'S TECH LEADERS
Share Issue/Capital Change Classification · 99% confidence The document is a press release announcing that LUMIBIRD has been selected for Euronext's 'Tech Leaders' program. It contains general company information, a quote from the CEO, and announces the date for the next financial update (first-half 2022 revenues). It is not a formal regulatory filing like a 10-K, an Earnings Release (ER) which contains actual results, or a specific financial report (IR, AR). Since it is a general announcement regarding company news and visibility, and it doesn't fit the specific categories like DIRS, DIV, or CAP, the most appropriate general category is Regulatory Filings (RNS), which serves as a fallback for miscellaneous official announcements not covered elsewhere, although it is primarily a press release.
2022-06-07 English
LUMIBIRD Informations relatives au nombre total de droits de vote et d’actions au 31/05/2022
Share Issue/Capital Change Classification · 95% confidence The document is very short (739 characters) and presents a table detailing the 'Nombre total de droits de vote et d'actions' (Total number of voting rights and shares) as of May 31, 2022. This type of mandatory disclosure, often related to capital structure and voting power, is typically filed with the French regulator (AMF) under specific articles (L.233-8 II du Code de commerce and 223-16 du Règlement général de l'AMF). While it relates to capital structure, it is a specific regulatory notification about voting rights rather than a general financing announcement (CAP) or a major shareholding change notification (MRQ, which usually reports ownership thresholds crossed by external parties). Given the specific nature of reporting total voting rights, it fits best under the general 'Regulatory Filings' (RNS) category as a specific, recurring regulatory disclosure that doesn't match the other specialized codes like DIV, SHA, or DIRS. It is not an announcement of a report (RPA) but the report itself, albeit a very brief one.
2022-06-03 French
LUMIBIRD MEDICAL STRENGTHENS ITS PRESENCE IN INDIA WITH THE CREATION OF A NEW SUBSIDIARY
Regulatory Filings Classification · 100% confidence The document is a press release dated June 2, 2022, announcing the creation of a new Indian subsidiary (Lumibird Medical India) to boost sales of existing products. It discusses market growth, operational history, and product focus. Crucially, it concludes with a 'Next date' section announcing 'first-half 2022 revenues on July 25, 2022'. This structure—a business update combined with an announcement of a future financial report release date—is characteristic of a general corporate announcement or a regulatory filing that isn't a full financial report (like 10-K or IR). Since it is a specific business development announcement (subsidiary creation) and not a standard earnings release (ER) or a report itself, it fits best under the general 'Regulatory Filings' (RNS) category, as it is an official communication to the market about a significant operational event, or potentially a Report Publication Announcement (RPA) if it were primarily announcing the publication of a report, which it is not. Given the content is a strategic business update, RNS is the most appropriate general category for non-standard, material announcements.
2022-06-02 English
LUMIBIRD MEDICAL RENFORCE SA PRESENCE EN INDE AVEC LA CREATION DE LA FILIALE LUMIBIRD MEDICAL INDIA
Regulatory Filings Classification · 95% confidence The document is a press release dated June 2, 2022, announcing the creation of a new subsidiary, Lumibird Medical India, to boost sales in the Indian ophthalmology market. It details market growth, company presence, and upcoming product showcases. Crucially, it concludes with a section titled 'Prochain rendez-vous: Publication du CA semestriel 2022, le 25/07/2022, après Bourse' (Next appointment: Publication of 2022 semi-annual revenue on 07/25/2022, after market close). This structure—a news announcement followed by a notice about a future financial report publication—strongly suggests this document is an announcement regarding the release of a future report, rather than the report itself (which would be an Interim Report (IR) or Earnings Release (ER)). Since it is a general corporate announcement about a future publication, it fits best under Report Publication Announcement (RPA). The document length (3783 chars) is also short, supporting the RPA classification over a full financial report.
2022-06-02 French
LUMIBIRD FINALISE L’ACQUISITION DE L’ACTIVITE TELEMETRES LASER DE DEFENSE DU GROUPE SAAB
Regulatory Filings Classification · 99% confidence The document announces the finalization of an acquisition by LUMIBIRD of the defense laser rangefinder business from SAAB. This is a significant corporate event related to mergers, acquisitions, or strategic business changes. Reviewing the definitions, the 'M&A Activity' (Code: TAR) is defined as 'Announcements and documents related to merger proposals or takeover bids.' Since this is a definitive announcement of a completed acquisition, TAR is the most appropriate classification. The document is short (2650 chars) but it is the primary announcement of the transaction itself, not just an announcement that a report will follow, thus it is not RPA or RNS.
2022-05-31 French
LUMIBIRD COMPLETES THE ACQUISITION OF SAAB GROUP’S DEFENSE LASER RANGEFINDER BUSINESS
M&A Activity Classification · 99% confidence The document announces the completion of an acquisition: "LUMIBIRD COMPLETES THE ACQUISITION OF SAAB GROUP'S DEFENSE LASER RANGEFINDER BUSINESS". This is a significant corporate action related to financing, capital structure, or business combination. Reviewing the definitions, the 'Capital/Financing Update (CAP)' category covers 'Updates on company fundraising, financing activities, or capital structure changes.' While M&A Activity (TAR) is also relevant, CAP is often used for the immediate announcement of the closing of a major transaction that alters the company's structure or financing base, especially when it's presented as a strategic move rather than just a bid. Given the context of completing a business acquisition, CAP is the most appropriate fit among the provided options, as it directly impacts the capital structure and strategic financing goals mentioned in the text ("fully aligned with the Lumibird Group's 2021-2023 strategic plan"). It is not an Earnings Release (ER), Interim Report (IR), or a general Regulatory Filing (RNS) because it describes a specific, material corporate event.
2022-05-31 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.